Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase

Add time:09/06/2019    Source:sciencedirect.com

A series of analogs of the potent HIV-1 integrase (HIV IN) inhibitor chicoric acid (CA) was designed with the intention of ameliorating some of the parent natural product’s undesirable properties, in particular its toxicity, instability, and poor membrane permeability. More than 70 analogs were synthesized and assayed for three types of activity: (1) the ability to inhibit 3′-end processing and strand transfer reactions using recombinant HIV IN in vitro, (2) toxicity against the CD4+ lymphoblastoid cell line, MT2, and (3) anti-HIV activity against HIVLAI. CA analogs lacking one of the carboxyl groups of CA and with 3,4,5-trihydroxycinnamoyl sidechains in place of the caffeoyl group of CA exhibited the most potent inhibition of HIV replication and end-processing activity. Galloyl-substituted derivatives also displayed very potent in vitro and in vivo activities, in most cases exceeding the inhibitory effects of CA itself. Conversely, analogous monocarboxy caffeoyl analogs exhibited only modest inhibition, while the corresponding 3,4-dihydroxybenzoyl-substituted compounds were devoid of activity.

We also recommend Trading Suppliers and Manufacturers of L-2,3-Diaminopropionic acid dihydrochloride (cas 19777-68-5). Pls Click Website Link as below: cas 19777-68-5 suppliers

Prev:Synthesis and X-ray crystal structures of Schiff bases prepared from salicylaldehyde and the diamino acids L-2-amino-3-methylaminopropanoic acid, DL-2,4-diamino-butanoic acid and DL-2,3-diaminopropanoic acid
Next:Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone☆)